BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20508203)

  • 1. Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Ishii N; Matsumura T; Kinoshita H; Fukuda K; Motoshima H; Senokuchi T; Nakao S; Tsutsumi A; Kim-Mitsuyama S; Kawada T; Takeya M; Miyamura N; Nishikawa T; Araki E
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1598-605. PubMed ID: 20508203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages.
    Bujold K; Rhainds D; Jossart C; Febbraio M; Marleau S; Ong H
    Cardiovasc Res; 2009 Aug; 83(3):457-64. PubMed ID: 19377069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARgamma through MAPK-dependent COX-2 expression in macrophages.
    Taketa K; Matsumura T; Yano M; Ishii N; Senokuchi T; Motoshima H; Murata Y; Kim-Mitsuyama S; Kawada T; Itabe H; Takeya M; Nishikawa T; Tsuruzoe K; Araki E
    J Biol Chem; 2008 Apr; 283(15):9852-62. PubMed ID: 18208815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages.
    Yano M; Matsumura T; Senokuchi T; Ishii N; Murata Y; Taketa K; Motoshima H; Taguchi T; Sonoda K; Kukidome D; Takuwa Y; Kawada T; Brownlee M; Nishikawa T; Araki E
    Circ Res; 2007 May; 100(10):1442-51. PubMed ID: 17463321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan exerts antiatherosclerotic effects by activating peroxisome proliferator-activated receptor-γ in macrophages.
    Matsumura T; Kinoshita H; Ishii N; Fukuda K; Motoshima H; Senokuchi T; Taketa K; Kawasaki S; Nishimaki-Mogami T; Kawada T; Nishikawa T; Araki E
    Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1268-75. PubMed ID: 21474824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway.
    Avallone R; Demers A; Rodrigue-Way A; Bujold K; Harb D; Anghel S; Wahli W; Marleau S; Ong H; Tremblay A
    Mol Endocrinol; 2006 Dec; 20(12):3165-78. PubMed ID: 16959872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
    Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H
    FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiatherosclerotic effect of farnesoid X receptor.
    Mencarelli A; Renga B; Distrutti E; Fiorucci S
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of L-type calcium channel blocking in epidermal growth factor receptor-independent activation of extracellular signal regulated kinase 1/2.
    Yin X; Polidano E; Faverdin C; Marche P
    J Hypertens; 2005 Feb; 23(2):337-50. PubMed ID: 15662222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GM-CSF deficiency reduces macrophage PPAR-gamma expression and aggravates atherosclerosis in ApoE-deficient mice.
    Ditiatkovski M; Toh BH; Bobik A
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2337-44. PubMed ID: 16873730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression.
    Tang FT; Cao Y; Wang TQ; Wang LJ; Guo J; Zhou XS; Xu SW; Liu WH; Liu PQ; Huang HQ
    Eur J Pharmacol; 2011 Jan; 650(1):275-84. PubMed ID: 20854809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo.
    Bursill CA; Castro ML; Beattie DT; Nakhla S; van der Vorst E; Heather AK; Barter PJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1773-8. PubMed ID: 20702809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation.
    Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
    Biochem Biophys Res Commun; 2009 Jul; 385(2):269-72. PubMed ID: 19460355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis.
    Ma L; Zhong J; Zhao Z; Luo Z; Ma S; Sun J; He H; Zhu T; Liu D; Zhu Z; Tepel M
    Cardiovasc Res; 2011 Dec; 92(3):504-13. PubMed ID: 21908651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray analysis of gene expression in mouse aorta reveals role of the calcium signaling pathway in control of atherosclerosis susceptibility.
    Yuan Z; Miyoshi T; Bao Y; Sheehan JP; Matsumoto AH; Shi W
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1336-43. PubMed ID: 19304945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor-gamma1 gene therapy attenuates atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice.
    Hu Q; Zhang XJ; Zhang C; Zhao YX; He H; Liu CX; Feng JB; Jiang H; Yang FL; Zhang CX; Zhang Y
    Hum Gene Ther; 2008 Mar; 19(3):287-299. PubMed ID: 18302511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol reduction and atherosclerosis inhibition by bezafibrate in low-density lipoprotein receptor knockout mice.
    Inaba T; Yagyu H; Itabashi N; Tazoe F; Fujita N; Nagashima S; Okada K; Okazaki M; Furukawa Y; Ishibashi S
    Hypertens Res; 2008 May; 31(5):999-1005. PubMed ID: 18712055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acidic extracellular pH increases calcium influx-triggered phospholipase D activity along with acidic sphingomyelinase activation to induce matrix metalloproteinase-9 expression in mouse metastatic melanoma.
    Kato Y; Ozawa S; Tsukuda M; Kubota E; Miyazaki K; St-Pierre Y; Hata R
    FEBS J; 2007 Jun; 274(12):3171-83. PubMed ID: 17540003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretion of apolipoprotein E from macrophages occurs via a protein kinase A and calcium-dependent pathway along the microtubule network.
    Kockx M; Guo DL; Huby T; Lesnik P; Kay J; Sabaretnam T; Jary E; Hill M; Gaus K; Chapman J; Stow JL; Jessup W; Kritharides L
    Circ Res; 2007 Sep; 101(6):607-16. PubMed ID: 17660382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.
    Yoshii T; Iwai M; Li Z; Chen R; Ide A; Fukunaga S; Oshita A; Mogi M; Higaki J; Horiuchi M
    Hypertens Res; 2006 Jun; 29(6):457-66. PubMed ID: 16940709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.